Amended Statement of Ownership (sc 13g/a)
October 10 2017 - 4:07PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THEREOF FILED PURSUANT TO § 240.13d-2
UNDER THE
SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
DarioHealth
Corp.
(Name of Issuer)
Shares of Common Stock
(Title of Class of Securities)
23725P100, 23725P118
(CUSIP Number)
April 12, 2017
(Date of Event Which Requires Filing of
this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
|
¨
|
Rule 13d-1(b)
|
|
|
|
|
x
|
Rule 13d-1(c)
|
|
|
|
|
¨
|
Rule 13d-1(d)
|
* The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No. 23725P100; 23725P118
|
13G
|
Page 2 of 6 Pages
|
1.
|
Names of Reporting Persons
Shehnee Lawrence Farhi
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(
See
Instructions)
(a)
¨
(b)
¨
|
3.
|
SEC Use Only
|
4.
|
Citizenship or Place of Organization
Canadian
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5.
|
Sole Voting Power
596,689(1)
|
6.
|
Shared Voting Power
0
|
7.
|
Sole Dispositive Power
596,689 (1)
|
8.
|
Shared Dispositive Power
0
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
596,689(1)
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(
See
Instructions)
|
¨
|
11.
|
Percent of Class Represented by Amount in Row (9)
5.7%
|
12.
|
Type of Reporting Person (
See
Instructions)
IN
|
|
|
|
|
|
(1) Reflects sole voting
/ dispositive power as of October 5, 2017. Includes 195,689 warrants to purchase common stock issued to the Reporting Person.
CUSIP No. 23725P100; 23725P118
|
13G
|
Page 3 of 6 Pages
|
|
Item 1(a).
|
Name of Issuer:
|
DarioHealth Corp.
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices:
|
9 Halamish Street, Caesarea Industrial
Park, 3088900, Israel
|
Item 2(a).
|
Name of Person Filing:
|
This Statement is filed on behalf
of Shehnee Lawrence Farhi (the “Reporting Person”).
|
Item 2(b).
|
Address of Principal Offices or, if None, Residence:
|
The address of the Reporting Person is:
413 Grangeover Crt., London,
Ontario, Canada.
Shehnee Lawrence Farhi is a Canadian
citizen.
|
Item 2(d).
|
Title of Class of Securities:
|
Shares of Common Stock
23725P100, 23725P118
|
Item 3.
|
If the Statement is being filed pursuant to Rule 13d-1(b)
or 13d-2(b) or (c), check whether the filing person is a:
|
Not applicable.
(a)
|
¨
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
|
|
|
(b)
|
¨
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
|
|
|
(c)
|
¨
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
|
|
|
(d)
|
¨
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
|
|
|
(e)
|
¨
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
|
|
(f)
|
¨
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
(g)
|
¨
|
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
|
|
(h)
|
¨
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
(i)
|
¨
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
|
|
|
|
(j)
|
¨
|
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
|
|
|
|
(k)
|
¨
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
CUSIP No. 23725P100; 23725P118
|
13G
|
Page 4 of 6 Pages
|
If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J),
please specify the type of institution:__________________________________________________________________________
(a) Amount beneficially
owned: 596,689 shares of Common Stock (consisting of (i) 401,000 shares of common stock held by the Reporting Person as of October
5, 2017, and (ii) 195,689 warrants to purchase common stock issued to the Reporting Person as of October 5, 2017.
(b) Percent of class:
5.7%
(c) Number of shares
as to which such person has:
|
(i)
|
Sole power to vote or direct the vote: 596,689
|
|
(ii)
|
Shared power to vote or direct the vote: 0
|
|
(iii)
|
Sole power to dispose or to direct the disposition of:
596,689
|
|
(iv)
|
Shared power to dispose or to direct the disposition of:
0
|
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed to report
the fact that as of the date hereof the reporting person had ceased to be the beneficial owner of more than 5 percent of the class
of securities, check the following [ ].
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another
Person.
|
Not applicable.
|
Item 7.
|
Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
Not applicable.
|
Item 8.
|
Identification and Classification of Members of the Group.
|
Not applicable.
|
Item 9.
|
Notice of Dissolution of Group.
|
Not applicable.
CUSIP No. 23725P100; 23725P118
|
13G
|
Page 5 of 6 Pages
|
(c) By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
CUSIP No. 23725P100; 23725P118
|
13G
|
Page 6 of 6 Pages
|
SIGNATURES
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
October 10, 2017
|
|
(Date)
|
|
|
|
/s/ Shehnee Lawrence Farhi
|
|
(Signature)
|
Attention.
Intentional misstatements or omissions of
fact constitute Federal criminal violations (s
ee
18 U.S.C. 1001).
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Apr 2023 to Apr 2024